Equities

Shanghai Aohua Photoelectricity Endoscope Co Ltd

688212:SHH

Shanghai Aohua Photoelectricity Endoscope Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)51.41
  • Today's Change-0.86 / -1.65%
  • Shares traded1.11m
  • 1 Year change-22.11%
  • Beta--
Data delayed at least 15 minutes, as of Nov 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Shanghai Aohua Photoelectricity Endoscope Co Ltd is a China-based company mainly engaged in the research and development of medical devices. The Company's main businesses are the research, development, production and sales of electronic endoscopic equipment and endoscopic diagnostic and surgical consumables. The Company's products include endoscopic equipment and endoscopic diagnostic and surgical consumables. The Company's products are mainly used in clinical departments such as gastroenterology, respiratory, ears, nose, and throat (ENT), gynecology, and emergency departments.

  • Revenue in CNY (TTM)750.04m
  • Net income in CNY49.97m
  • Incorporated1994
  • Employees1.09k
  • Location
    Shanghai Aohua Photoelectricity Endoscope Co LtdNo.660 Shengang Road, Songjiang DistrictSHANGHAI 201108ChinaCHN
  • Phone+86 2 154303731
  • Fax+86 2 167681020
  • Websitehttps://www.aohua.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Innovita Biological Technology Co Ltd720.40m332.01m5.87bn404.0017.612.87--8.152.442.445.3014.980.35843.189.161,783,177.0016.52--17.42--80.70--46.09--16.01--0.001--7.03--15.44------
Zhende Medical Co Ltd4.04bn205.34m6.17bn6.72k30.131.11--1.530.76840.768415.1920.950.51913.126.43601,941.302.8517.133.6123.5434.1638.055.4917.331.8038.530.146529.85-32.7623.63-70.878.7921.4647.58
Zhejiang Orient Gene Biotech Co Ltd825.60m-587.36m6.72bn2.23k--0.9766--8.14-2.93-2.934.1434.130.09491.173.19370,058.00-7.1829.62-8.2738.2939.2659.69-75.7335.823.71--0.074419.24-90.6523.46-119.23--121.04--
Shanghai Aohua Phtlctrcty Endscp Co Ltd750.04m49.97m7.03bn1.09k129.945.09--9.380.40230.40235.5610.270.46821.013.34686,850.103.264.373.664.8068.8869.256.9710.913.33--0.081531.5152.2934.25166.42--20.42--
Shenzhen Lifotronic Technology Co Ltd1.19bn381.08m7.16bn1.48k18.773.67--6.000.89090.89092.794.550.48342.277.49805,792.8015.3713.8221.0916.3367.0661.0131.7926.102.25--0.243441.5116.5528.7830.6632.27-7.91--
HOB Biotech Group Corp Ltd401.29m35.26m7.44bn550.00210.199.11--18.540.56140.56146.3512.950.41021.378.23729,609.803.609.944.3312.1061.8765.308.7919.530.943839.420.119232.5923.1014.3813.643.3446.19--
Data as of Nov 15 2024. Currency figures normalised to Shanghai Aohua Photoelectricity Endoscope Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

40.54%Per cent of shares held by top holders
HolderShares% Held
China Universal Asset Management Co., Ltd.as of 30 Jun 202411.35m12.32%
China Asset Management Co., Ltd.as of 30 Jun 20248.08m8.77%
ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Jun 20245.40m5.86%
E Fund Management Co., Ltd.as of 30 Jun 20243.93m4.27%
Galaxy Asset Management Co., Ltd.as of 30 Jun 20242.33m2.53%
New China Fund Management Co., Ltd.as of 30 Jun 20242.20m2.39%
Golden Trust Sinopac Fund Management Co., Ltd.as of 30 Jun 20241.10m1.19%
Harfor Fund Management Co., Ltd.as of 30 Jun 20241.04m1.13%
Huisheng Fund Management Co., Ltd.as of 30 Jun 2024963.55k1.05%
Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024950.90k1.03%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.